Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome.
Rossi
Davide
D
Bodoni
Chiara Lobetti
CL
Zucchetto
Antonella
A
Rasi
Silvia
S
De Paoli
Lorenzo
L
Fangazio
Marco
M
Rossi
Francesca Maria
FM
Ladetto
Marco
M
Gattei
Valter
V
Gaidano
Gianluca
G
D000368:Aged; D015415:Biomarkers; D014408:Biomarkers, Tumor; D002869:Chromosome Aberrations; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D016158:Genes, p53; D042822:Genomic Instability; D006801:Humans; D039441:Integrin alpha4 / Q000032:analysis* / Q000096:biosynthesis; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D016615:Telomere / Q000648:ultrastructure*; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000097:blood
D015415:Biomarkers; D014408:Biomarkers, Tumor; D039441:Integrin alpha4; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human